Document is current
Any future updates will be listed below
-
Authors
Erdem, Simge https://orcid.org/0000-0001-8095-5445
Bayrak Tokaç, Ayşe Gül https://orcid.org/0000-0003-2228-0632
Aday, Aynur https://orcid.org/0000-0001-8072-0646
Karaca, Dilan https://orcid.org/0009-0001-2490-3613
Mutlu, Mehmet Burak https://orcid.org/0000-0001-7745-8165
Çefle, Kıvanç https://orcid.org/0000-0002-9420-4543
Yenerel, Mustafa Nuri https://orcid.org/0000-0002-6473-1342
Öztürk, Şükrü https://orcid.org/0000-0002-8809-7462
Kalayoğlu Beşışık, Sevgi https://orcid.org/0000-0002-9310-1278
-
Funding
Funding for this research was provided by:
Scientific Research Projects Coordination Unit of Istanbul University (39464)
- License Information
-
More Information
Article History
Received: 21 July 2025
Accepted: 1 October 2025
First Online: 3 November 2025
Declarations
:
: Ethical approval (Date: 11/11/2022; Number: 20) from the Istanbul University Istanbul Faculty of Medicine Clinical Research Ethics Committee and written informed consent from the patients were obtained for the study, which was conducted in accordance with the Declaration of Helsinki.
: Written informed consent for publication from the patients was obtained.
: MBM works for a genetic disease evaluation company that is the distributor of OGM technology in Turkiye. The other authors declare that they have no competing interests.
